GeneDx Holdings Corp (WGS)

Currency in USD
77.08
+7.49(+10.76%)
Closed·
76.94-0.14(-0.18%)
·

WGS Earnings

Latest Release
Aug 03, 2026
EPS / Forecast
-0.28 / -0.14
Revenue / Forecast
114.4M / 111.01M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/0.103--/126.06M----Free Sign Up
06/2026-0.280/-0.140114.40M/111.01M-100%+3.05%Free Sign Up
03/2026-0.280/-0.010102.30M/112.45M-2,700%-9.03%Free Sign Up
12/2025-0.610/0.090121.00M/120.55M-777.78%+0.37%Free Sign Up
09/20250.490/0.410116.74M/104.33M+19.51%+11.89%Free Sign Up
06/20250.500/0.120102.70M/85.45M+316.67%+20.19%Free Sign Up
03/2025-0.230/0.06087.10M/78.00M-483.33%+11.67%Free Sign Up
12/20240.080/-0.48095.30M/61.70M+116.67%+54.46%Free Sign Up
09/20240.040/-0.57076.60M/58.79M+107.04%+30.29%Free Sign Up
06/2023-1.64/-1.3153.00M/47.64M-25.19%+11.25%Free Sign Up

All numbers in USD

GeneDx Holdings Corp Earnings Call Summary for Q2/2026

  • GeneDx Q2 revenue hit $114.4M, beating forecasts by 3.05%; achieved adjusted net income of $0.4M one quarter ahead of plan despite EPS miss of $0.28.
  • Exome and genome test volume surged 32% YoY to record 30,785 tests; gross margin improved to 70% after completing $25M in annual cost reductions.
  • Shares jumped 15.1% to $75 in after-hours trading on strong volume growth and earlier-than-expected profitability milestone.
  • Company reaffirmed 2026 guidance of $475M-$490M revenue with 30%+ volume growth; Q3 revenue expected at $122M-$124M with ~$2M adjusted net income.
  • Management prioritizes revenue cycle improvements to boost collection rates toward 70% industry standard, with biggest gains expected in 2027 from payer coverage.
Last Updated: 08/04/2026, 05:40 AM
Read Full Transcript

FAQ

What Is GeneDx Holdings's Earnings Per Share (TTM)?

The GeneDx Holdings EPS (TTM) is -3.64.

When Is The Next GeneDx Holdings Earnings Date?

GeneDx Holdings will release its next earnings report on Nov 03, 2026.

What Is GeneDx Holdings’s Revenue Forecasts For Upcoming Quarters?

GeneDx Holdings’s revenue forecast is 126.06M.

How Did GeneDx Holdings React to the Company's Latest Earnings Report?

GeneDx Holdings reported a -100% EPS surprise and a +3.05% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 8.89%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.